APA (7th ed.) Citation

Sabha, N., Deimling, A. v., & Capper, D. (2014). Analysis of IDH mutation, 1p/19q deletion, and PTEN loss delineates prognosis in clinical low-grade diffuse gliomas. Neuro-Oncology, 16(7), . https://doi.org/10.1093/neuonc/not299

Chicago Style (17th ed.) Citation

Sabha, Nesrin, Andreas von Deimling, and David Capper. "Analysis of IDH Mutation, 1p/19q Deletion, and PTEN Loss Delineates Prognosis in Clinical Low-grade Diffuse Gliomas." Neuro-Oncology 16, no. 7 (2014). https://doi.org/10.1093/neuonc/not299.

MLA (9th ed.) Citation

Sabha, Nesrin, et al. "Analysis of IDH Mutation, 1p/19q Deletion, and PTEN Loss Delineates Prognosis in Clinical Low-grade Diffuse Gliomas." Neuro-Oncology, vol. 16, no. 7, 2014, https://doi.org/10.1093/neuonc/not299.